156 related articles for article (PubMed ID: 30908362)
1. Sentinel Lymph Node Biopsy in Patients With Acral Melanoma: Analysis of 201 Cases From the Brazilian National Cancer Institute.
Nunes LF; Mendes GLQ; Koifman RJ
Dermatol Surg; 2019 Aug; 45(8):1026-1034. PubMed ID: 30908362
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node status predicts survival in thick melanomas: the Oxford perspective.
Rughani MG; Swan MC; Adams TS; Marshall A; Asher R; Cassell OC; Middleton MR
Eur J Surg Oncol; 2012 Oct; 38(10):936-42. PubMed ID: 22617251
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy.
Wu CE; Hsieh CH; Chang CJ; Yeh JT; Kuo TT; Yang CH; Lo YF; Lin KJ; Lin YC; Chang JW
J Formos Med Assoc; 2015 May; 114(5):415-21. PubMed ID: 23969039
[TBL] [Abstract][Full Text] [Related]
6. Subungual melanoma: A retrospective cohort of 157 cases from Brazilian National Cancer Institute.
Nunes LF; Mendes GLQ; Koifman RJ
J Surg Oncol; 2018 Dec; 118(7):1142-1149. PubMed ID: 30261102
[TBL] [Abstract][Full Text] [Related]
7. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
Monroe MM; Pattisapu P; Myers JN; Kupferman ME
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
[TBL] [Abstract][Full Text] [Related]
8. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy status is strongly predictive of survival in cutaneous melanoma: Extended follow-up of Oxford patients from 1998 to 2014.
Thomson DR; Rughani MG; Kuo R; Cassell OCS
J Plast Reconstr Aesthet Surg; 2017 Oct; 70(10):1397-1403. PubMed ID: 28625757
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: a single institution experience.
Homolak D; Šitum M; Čupić H
Acta Dermatovenerol Croat; 2015; 23(2):122-9. PubMed ID: 26228823
[TBL] [Abstract][Full Text] [Related]
11. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
Ranieri JM; Wagner JD; Wenck S; Johnson CS; Coleman JJ
Ann Surg Oncol; 2006 Jul; 13(7):927-32. PubMed ID: 16788753
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD
Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474
[TBL] [Abstract][Full Text] [Related]
13. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy status is a key parameter to stratify the prognostic heterogeneity of malignant melanoma in high-risk tumors >4.0 mm.
Göppner D; Ulrich J; Pokrywka A; Peters B; Gollnick H; Leverkus M
Dermatology; 2011 Feb; 222(1):59-66. PubMed ID: 21196701
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data.
Chen J; Xu Y; Zhou Y; Wang Y; Zhu H; Shi Y
Oncotarget; 2016 Jul; 7(29):45671-45677. PubMed ID: 27344178
[TBL] [Abstract][Full Text] [Related]
16. The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival.
Fortes C; Mastroeni S; Caggiati A; Passarelli F; Zappalà A; Capuano M; Bono R; Nudo M; Marino C; Michelozzi P
Am J Surg; 2016 Nov; 212(5):935-940. PubMed ID: 27266393
[TBL] [Abstract][Full Text] [Related]
17. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
Pavri SN; Han G; Khan S; Han D
J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
[TBL] [Abstract][Full Text] [Related]
18. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
19. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
20. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
